Summary
- Revenue
- BGNE current annual revenue is $2.46B, up +73.65% year-over-year
- Next Earnings
- As of today, the next earnings release for BGNE has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | BeiGene, Ltd. |
| Ticker | NASDAQ: BGNE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Cayman Islands |
| IPO | |
| Indexes | Not included |
| Website | beigene.com |
| Employees | 10,600 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| - | ||
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| - | N/A | |
| $2.46B | ||
| Revenue, 1Y Change | +73.65% | |
| -$8.45 | ||
| EPS, 1Y Change | +56.38% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$8.45 | ||
| EPS Estimate | -$4.90 | N/A |
| EPS Est. Change | +42.00% | N/A |
| $2.46B | ||
| Revenue Estimate | $3.71B | N/A |
| Revenue Est. Change | +50.73% | N/A |
| - | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$8.60 | -$8.45 | +1.74% | |
| -$4.90 | N/A | +42.00% | |
| -$0.56 | N/A | +93.34% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.45B | $2.46B | +0.18% | |
| $3.71B | N/A | +50.73% | |
| $4.67B | N/A | +89.98% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| +73.65% | ||
| +696.05% | ||
| +56.38% | ||
| +56.67% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| - | ||
| - |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $2.46B | ||
| -$8.45 | ||
| $2.08B | ||
| 84.55% | ||
| -$1.21B | ||
| -49.12% | ||
| -$881.71M | ||
| -35.86% | ||
| -$1.12B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.25 | ||
| 2.32 | ||
| 2.09 | ||
| - | ||
| 3 | ||
| - |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $3.54B | ||
| $3.17B | ||
| $5.81B | ||
| $4.20B | ||
| $2.27B | ||
| $1.81B | ||
| $930.19M | ||
| $710.32M | ||
| $315.11M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $3.67B | ||
| $3.29B | ||
| $379.92M | ||
| $1.50B | ||
| $87.68M | ||
| - | ||
| $55.87M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$1.16B | ||
| $60.00M | ||
| $416.48M | ||
| $596.26M | ||
| -$1.75B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| TD Cowen | → | |
| JP Morgan | → | |
| JMP Securities | ||
| JP Morgan | → | |
| Citigroup | → | |
| B of A Securities | → | |
| TD Cowen | → | |
| TD Cowen | → | |
| B of A Securities | → | |
| Bernstein | → |
Analyst sentiment
Institutional ownership
Screeners with BGNE
FAQ
- What is the ticker symbol for BeiGene, Ltd.?
- The ticker symbol for BeiGene, Ltd. is NASDAQ:BGNE
- Does BeiGene, Ltd. pay dividends?
- No, BeiGene, Ltd. does not pay dividends
- What sector is BeiGene, Ltd. in?
- BeiGene, Ltd. is in the Healthcare sector
- What industry is BeiGene, Ltd. in?
- BeiGene, Ltd. is in the Biotechnology industry
- What country is BeiGene, Ltd. based in?
- BeiGene, Ltd. is headquartered in Cayman Islands
- When did BeiGene, Ltd. go public?
- BeiGene, Ltd. initial public offering (IPO) was on February 3, 2016
- Is BeiGene, Ltd. in the S&P 500?
- No, BeiGene, Ltd. is not included in the S&P 500 index
- Is BeiGene, Ltd. in the NASDAQ 100?
- No, BeiGene, Ltd. is not included in the NASDAQ 100 index
- Is BeiGene, Ltd. in the Dow Jones?
- No, BeiGene, Ltd. is not included in the Dow Jones index
- When was BeiGene, Ltd. last earnings report?
- BeiGene, Ltd.'s most recent earnings report was on February 26, 2025
- When does BeiGene, Ltd. report earnings?
- The date for BeiGene, Ltd.'s next earnings report has not been announced yet
Data Sources & References
- BGNE Official Website www.beigene.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1651308/000165130824000014/0001651308-24-000014-index.htm
- BGNE Profile on Yahoo Finance finance.yahoo.com/quote/BGNE
- BGNE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bgne